Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Perera

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Influenza Hemagglutination-inhibition Antibody Titer as a Mediator of Vaccine-induced Protection for Influenza BBenjamin J Cowling, Wey Wen Lim, Ranawaka A P M Perera, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 18, 2015
Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015Daniel K W Chu, Jamiu O Oladipo, Ranawaka A P M Perera, et al.
Epidemiology and Infection|May 3, 2014
Multivariate analysis of factors affecting the immunogenicity of trivalent inactivated influenza vaccine in school-age childrenG Freeman, S Ng, R A P M Perera, et al.
Emerging Infectious Diseases|January 30, 2026
Enhanced Isolation and Detection of COVID-19 in Hospitalized Patients Undergoing Antiviral TherapyRanawaka A P M Perera, Andrew Marques, Jevon Graham-Wooten, et al.
Emerging Infectious Diseases|April 21, 2022
Determining Existing Human Population Immunity as Part of Assessing Influenza Pandemic RiskJonathan Tin Lai Cheung, Tim K Tsang, Hui-Ling Yen, et al.
The Journal of Infectious Diseases|April 5, 2022
Biphasic Waning of Hemagglutination Inhibition Antibody Titers After Influenza Vaccination in ChildrenWeijia Xiong, Tim K Tsang, Ranawaka A P M Perera, et al.
Epidemiology (Cambridge, Mass.)|October 3, 2015
Interpreting Seroepidemiologic Studies of Influenza in a Context of Nonbracketing SeraTim K Tsang, Vicky J Fang, Ranawaka A P M Perera, et al.
Nature Communications|April 12, 2019
Age-specific differences in the dynamics of protective immunity to influenzaSylvia Ranjeva, Rahul Subramanian, Vicky J Fang, et al.
Viruses|February 26, 2022
SARS-CoV-2 Delta Variant (AY.3) in the Feces of a Domestic CatOlivia C Lenz, Andrew D Marques, Brendan J Kelly, et al.
The Journal of Infectious Diseases|March 29, 2014
Association between antibody titers and protection against influenza virus infection within householdsTim K Tsang, Simon Cauchemez, Ranawaka A P M Perera, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Influenza Hemagglutination-inhibition Antibody Titer as a Mediator of Vaccine-induced Protection for Influenza BBenjamin J Cowling, Wey Wen Lim, Ranawaka A P M Perera, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 18, 2015
Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015Daniel K W Chu, Jamiu O Oladipo, Ranawaka A P M Perera, et al.
Epidemiology and Infection|May 3, 2014
Multivariate analysis of factors affecting the immunogenicity of trivalent inactivated influenza vaccine in school-age childrenG Freeman, S Ng, R A P M Perera, et al.
Emerging Infectious Diseases|January 30, 2026
Enhanced Isolation and Detection of COVID-19 in Hospitalized Patients Undergoing Antiviral TherapyRanawaka A P M Perera, Andrew Marques, Jevon Graham-Wooten, et al.
Emerging Infectious Diseases|April 21, 2022
Determining Existing Human Population Immunity as Part of Assessing Influenza Pandemic RiskJonathan Tin Lai Cheung, Tim K Tsang, Hui-Ling Yen, et al.
The Journal of Infectious Diseases|April 5, 2022
Biphasic Waning of Hemagglutination Inhibition Antibody Titers After Influenza Vaccination in ChildrenWeijia Xiong, Tim K Tsang, Ranawaka A P M Perera, et al.
Epidemiology (Cambridge, Mass.)|October 3, 2015
Interpreting Seroepidemiologic Studies of Influenza in a Context of Nonbracketing SeraTim K Tsang, Vicky J Fang, Ranawaka A P M Perera, et al.
Nature Communications|April 12, 2019
Age-specific differences in the dynamics of protective immunity to influenzaSylvia Ranjeva, Rahul Subramanian, Vicky J Fang, et al.
Viruses|February 26, 2022
SARS-CoV-2 Delta Variant (AY.3) in the Feces of a Domestic CatOlivia C Lenz, Andrew D Marques, Brendan J Kelly, et al.
The Journal of Infectious Diseases|March 29, 2014
Association between antibody titers and protection against influenza virus infection within householdsTim K Tsang, Simon Cauchemez, Ranawaka A P M Perera, et al.
Pageof 9